Obenauf Lab

Very happy to share our new study led by my brilliant PhD student Lisa Haas with the help of the whole lab and our all-Star collaborators.

A new study led by the lab of Anna Obenauf shows how skin tumours that acquire resistance to targeted therapy are likely to be resistant to subsequent immunotherapy, a completely different form of treatment. Good timing for !

https://www.imp.ac.at/news/article/cross-resistance-when-cancer-therapy-backfires/

Check out this fantastic piece of work and consider doing a postdoc in the Ganesh lab at MSKCC. A new lab to watch out for!

L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer The authors identify a population of L1CAM-positive cells that, following loss of epithelial integrity, promote intestinal tissue regeneration and mediate metastasis initiation and chemoresistance in colorectal cancer.

Immunology group leader wanted.

www.imp.ac.at